Therapeutic Pipeline

Early-stage Biotech Company bringing therapeutic solutions to COVID-19 & other respiratory diseases using repurposed drugs and/or new routes of administration, and innovative science for diagnostics

EARLY STAGE

CLINICAL

COMERCIAL

Solution for Nebulization SARS COV-2 (USR001)

Inhaler – SARS COV-2

SARS CoV-2 Biomarker

Influenza

Herpes virus Type 1

Subscribe for Information & Updates